A study led by the Innovation in Vesicles and Cells for Application in Therapy (IVECAT) group at the Germans Trias i Pujol Research Institute (IGTP) has identified a key mechanism regulating the anti-inflammatory function of extracellular vesicles derived from mesenchymal stromal cells. The findings, published in the Journal of Extracellular Vesicles, provide new insights into the therapeutic potential of these vesicles in inflammatory diseases and ischemic processes.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗